Perspectives
Published Editorials and Industry Updates
Welcome to Perspectives, our blog designed to keep members, oncology stakeholders, and anyone interested in enhancing the care experience for oncology patients informed on critical issues. You’ll hear from thought leaders and learn about the impact and benefits of medically integrated pharmacy, operational insights designed to support you in the day-to-day delivery of care, as well as timely industry issues facing oncology pharmacy professionals.
One Quarter in the Rearview Mirror: A Discussion of DIR Fee Transitions
May 2, 2024
By: NCODA Editorial Team While the industry continues to work toward greater transparency, the changes to the direct and indirect remuneration (DIR) fees in 2024 have been a significant topic for our member organizations. Over the years, DIR fees have caused confusion and financial surprises for pharmacies across the U.S. given implementation and differences […]
read more
Driving Quality Patient Care and Enhancing Outcomes – Asembia 2024
April 30, 2024
Attending Asembia 2024- Access to Pharmacy in Las Vegas? NCODA will be there advancing the discussion on priority topics like patient centered care, cost and accessibility to medication for patients, collaboration and of course the advantages of medically integrated care within the oncology space. On Wednesday, May 1, NCODA founder and Executive Director Michael Reff […]
read more
Equitable Impact of Clinical Pharmacists on Oncology Patient Care
April 18, 2024
Practice interviews and survey results to understand how pharmacists at select medically integrated dispensing (MID) pharmacies help deliver equitable oncology patient care NCODA, in collaboration with Pfizer Oncology, conducted an online survey of its members in summer 2023 to better understand disparities in oncology care for older adults. This survey revealed that most practice sites […]
read more
2024 NCODA International Spring Forum
April 3, 2024
NCODA is looking forward to kicking off the 2024 International Spring Forum in Dallas this afternoon. The Forum, Driving Optimal Strategies for Patient Care in Medically Integrated Oncology, runs April 3-5 and will feature insights and presentations for enhancing coordination and patient outcomes for every member of the integrated care team. The agenda is designed […]
read more
Learnings from the Change Healthcare Shutdown in Delivering Continuous Care
March 14, 2024
NCODA Executive Council Member Lucio N. Gordan of Florida Cancer Specialists & Research Institute Florida Cancer Specialists & Research Institute shares insight and thoughts on the ongoing Change Healthcare issue and the importance of keeping patient care at the forefront. We appreciate all member practices for working diligently to support patients and their needs during […]
read more
Maintaining Patient Coordination at the Pharmacy Level is Essential to Care
February 23, 2024
By: Stacey McCullough, PharmD, Chief Pharmacy Officer at NCODA Medicare patients are some of the heaviest users of our healthcare system and require the most pharmacy support to manage both chronic and episodic health needs. According to the Kaiser Family Foundation analysis of National Health Expenditure data from CMS, Medicare’s contribution to total national health […]
read more
STARK LAW FAQ CREATES NEW CHALLENGES FOR MEDICALLY INTEGRATED PHARMACIES
November 20, 2023
The federal Ethics in Patient Referrals Act — more commonly referred to as the Stark Law — prohibits physicians and other healthcare professionals from referring Medicare and Medicaid patients to facilities in which they or their immediate family members have ownership or invested interest. The law was created to address concerns of “self-referral” policies where […]
read more
BEYOND THE FIRST FILL
November 1, 2023
HOW 5 NCODA PRACTICES WERE EMPOWERED TO TAKE THE NEXT STEP IN IMPROVING PATIENT CARE By Bill Wimbiscus Oncolytics Today Editor There’s a moment in the life of nearly every oral oncology patient, a moment that can have a profound effect on their treatment outcome. That moment occurs immediately after the “first fill” of their […]
read more
BIRTH OF AN ORAL ONCOLYTIC
October 25, 2023
THE QUEST FOR A NEW CANCER DRUG IS NOT FOR THE FAINT OF HEART By Brett Williams, PhD With 10 new FDA approvals in the second half of 2019 alone, the toolbox of oral oncolytics is continuously expanding. These new approvals present patients and providers alike with new therapeutic options, but also bring the […]
read more
THE UNDERLYING BIAS OF PHARMACOGENOMICS
October 24, 2023
RACIAL EXCLUSION IN CANCER CLINICAL TRIALS HAS LEFT BEHIND THE POPULATIONS MOST IN NEED OF TREATMENT By Porscha Johnson, PharmD, CPGx While research has led to profound advancements in cancer treatments — including antibody-drug conjugates and immunotherapy, as well as the utilization of pharmacogenomics to aim for precision medicine through gene-drug matched targeted therapy — […]
read more
IT’S TIME FOR CONGRESS TO BAN ALTERNATIVE FUNDING PROGRAMS
October 24, 2023
By Amy Niles, MBA Employer-sponsored health plans use alternative funding programs (AFPs) as a way to lower their costs by forcing patients who need specialty medications to search for funding elsewhere. This often leads to patients delaying or going without their critical treatment that should have been covered by their health plan from the start. […]
read more
RESOURCES
Cost Avoidance Waste Tracker
Positive Quality Interventions
PQI in Action
OCE Sheets
IVE Sheets
Treatment Support Kits
PQI Podcast
Members
Member Resources
OPTA
Committees
Member Login
Events
Webinars
Spring Forum
Oncology Institute
PSO Annual Meeting
Fall Summit
contact@ncoda.org
315-655-4640
P.O. Box 468
Cazenovia, NY 13035
